QuilliChew ER® (methylphenidate hydrochloride)
for Attention Deficit Hyperactivity Disorder

QuilliChew ER (methylphenidate hydrochloride) is a cherry-flavored, chewable extended-release tablet used to treat ADHD. Taken once daily in the morning, it contains methylphenidate hydrochloride, a central nervous system stimulant. While its exact mechanism is unknown, QuilliChew ER increases brain activity in areas that regulate behavior and attention by boosting dopamine and noradrenaline levels, which are often low in people with ADHD.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Attention Deficit Hyperactivity Disorder - ADHD